Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ularitide in cirrhosis patients with refractory ascites
2019-002268-28Phase 2Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cirrhosis comparing Ularitide with Placebo (2 arms). Primary endpoint: Change in sodium excretion rate. Started Jan 2020; status: terminated.
02
Drugs
ularitide
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2019-002268-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002268-28.